アプレピタント注射剤の世界市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別Global Aprepitant Injection Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application アレピダン注射剤は、アレピダンを大豆油で包んだサブミクロン乳剤である。経口製剤と比較して、バイオアベイラビリティ(生物学的利用能)と服薬コンプライアンスを大幅に改善することができ、同時に、類似の注... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーアレピダン注射剤は、アレピダンを大豆油で包んだサブミクロン乳剤である。経口製剤と比較して、バイオアベイラビリティ(生物学的利用能)と服薬コンプライアンスを大幅に改善することができ、同時に、類似の注射製剤の臨床使用におけるアナフィラキシーの発生率を効果的に減少させることができる。化学療法による悪心・嘔吐の処方薬である。単独または他の薬剤と併用することができる。QYResearch発行のAprepitant Injectionに関する調査レポートは、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。Aprepitant Injectionの世界市場は、2023年から2029年の間に年平均成長率%で、2022年の100万米ドルから増加し、2029年には100万米ドルに達すると予測されています。癌治療センターと病院からの需要が業界の主要な推進力である。 北米、ヨーロッパ、アジア太平洋地域は、アプレピタント注射剤産業の主要地域である。これらの地域の中で、川下産業からの旺盛な需要に刺激され、アジア太平洋地域は2023年から2029年の間にCAGR %で急成長を遂げると推定されている。 世界的に、Aprepitant Injectionの主要メーカーには、Heron Therapeutics, Inc.やQilu Pharmaceuticalなどがあります。Heron Therapeutics, Inc.、Qilu Pharmaceuticalは上位3社で、2022年の売上高シェアは合計で%でした。 アプレピタント注射剤は、注射剤と注射ローション剤などに分けられます。注射剤は市場の主流製品であり、2022年の世界売上高シェアは注射剤が占める。 Aprepitant注射剤は癌治療センター、病院など様々な分野で広く使われている。癌治療センターはAprepitant Injection産業の発展に最大のサポートを提供する。2022年、Aprepitant注射剤の世界売上シェアは癌治療センターが占める。 レポートの範囲 本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界のアプレピタント注市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分なサポートを提供します。 レポート掲載メーカー、タイプ、用途、地域 企業別 ヘロン・セラピューティクス社 Qilu Pharmaceutical タイプ別 注射剤 注射ローション 用途別セグメント 癌治療センター 病院 地域別セグメント 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 インド オーストラリア 中国 台湾 東南アジア ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 本レポートの各章は、読者がアプレピタント注射剤市場をさらに理解するための詳細な情報を提供します: 第1章:2018年から2023年までの北米、欧州、アジア太平洋、中南米、中東およびアフリカにおける製品定義、製品タイプ、各タイプの数量および収益分析。 第2章:売上高と収益の比較を含むメーカーの競争状況、Aprepitant Injectionのメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、Aprepitant Injection業界で発生した拡張活動。 第3章:北米、欧州、アジア太平洋、中南米、中東、アフリカにおけるアプレピタント注射剤の過去(2018年-2022年)および予測(2023年-2029年)の数量と収益分析。 第4章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。 第5章から第9章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。 第10章:メーカー概要:本社、連絡先、主要事業、アプレピタント注射剤の紹介など、企業の基本情報を網羅する。また、各社の売上高、収益、価格、グロスマージン、最近の動向もこの部分に含まれています。 第11章:原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。 第12章:市場チャネル、流通業者と顧客がリストアップされています。 第13章包括的な調査に基づくアプレピタント注射剤市場のQYResearchの結論。 第14章:QYResearchが採用した方法論とデータソース。 目次1 Aprepitant Injection Market Overview1.1 Aprepitant Injection Product Overview 1.2 Aprepitant Injection Market Segment by Type 1.2.1 Injection 1.2.2 Injection Lotion 1.3 Global Aprepitant Injection Market Size by Type 1.3.1 Global Aprepitant Injection Market Size Overview by Type (2018-2029) 1.3.2 Global Aprepitant Injection Historic Market Size Review by Type (2018-2023) 1.3.3 Global Aprepitant Injection Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.2 Europe Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Type (2018-2023) 2 Global Aprepitant Injection Market Competition by Company 2.1 Global Top Players by Aprepitant Injection Sales (2018-2023) 2.2 Global Top Players by Aprepitant Injection Revenue (2018-2023) 2.3 Global Top Players by Aprepitant Injection Price (2018-2023) 2.4 Global Top Manufacturers Aprepitant Injection Manufacturing Base Distribution, Sales Area, Product Type 2.5 Aprepitant Injection Market Competitive Situation and Trends 2.5.1 Aprepitant Injection Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Aprepitant Injection Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aprepitant Injection as of 2022) 2.7 Date of Key Manufacturers Enter into Aprepitant Injection Market 2.8 Key Manufacturers Aprepitant Injection Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Aprepitant Injection Status and Outlook by Region 3.1 Global Aprepitant Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Aprepitant Injection Historic Market Size by Region 3.2.1 Global Aprepitant Injection Sales in Volume by Region (2018-2023) 3.2.2 Global Aprepitant Injection Sales in Value by Region (2018-2023) 3.2.3 Global Aprepitant Injection Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Aprepitant Injection Forecasted Market Size by Region 3.3.1 Global Aprepitant Injection Sales in Volume by Region (2024-2029) 3.3.2 Global Aprepitant Injection Sales in Value by Region (2024-2029) 3.3.3 Global Aprepitant Injection Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Aprepitant Injection by Application 4.1 Aprepitant Injection Market Segment by Application 4.1.1 Cancer Treatment Center 4.1.2 Hospital 4.2 Global Aprepitant Injection Market Size by Application 4.2.1 Global Aprepitant Injection Market Size Overview by Application (2018-2029) 4.2.2 Global Aprepitant Injection Historic Market Size Review by Application (2018-2023) 4.2.3 Global Aprepitant Injection Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.2 Europe Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Application (2018-2023) 5 North America Aprepitant Injection by Country 5.1 North America Aprepitant Injection Historic Market Size by Country 5.1.1 North America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Aprepitant Injection Sales in Volume by Country (2018-2023) 5.1.3 North America Aprepitant Injection Sales in Value by Country (2018-2023) 5.2 North America Aprepitant Injection Forecasted Market Size by Country 5.2.1 North America Aprepitant Injection Sales in Volume by Country (2024-2029) 5.2.2 North America Aprepitant Injection Sales in Value by Country (2024-2029) 6 Europe Aprepitant Injection by Country 6.1 Europe Aprepitant Injection Historic Market Size by Country 6.1.1 Europe Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Aprepitant Injection Sales in Volume by Country (2018-2023) 6.1.3 Europe Aprepitant Injection Sales in Value by Country (2018-2023) 6.2 Europe Aprepitant Injection Forecasted Market Size by Country 6.2.1 Europe Aprepitant Injection Sales in Volume by Country (2024-2029) 6.2.2 Europe Aprepitant Injection Sales in Value by Country (2024-2029) 7 Asia-Pacific Aprepitant Injection by Region 7.1 Asia-Pacific Aprepitant Injection Historic Market Size by Region 7.1.1 Asia-Pacific Aprepitant Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Aprepitant Injection Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Aprepitant Injection Forecasted Market Size by Region 7.2.1 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Aprepitant Injection Sales in Value by Region (2024-2029) 8 Latin America Aprepitant Injection by Country 8.1 Latin America Aprepitant Injection Historic Market Size by Country 8.1.1 Latin America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Aprepitant Injection Sales in Volume by Country (2018-2023) 8.1.3 Latin America Aprepitant Injection Sales in Value by Country (2018-2023) 8.2 Latin America Aprepitant Injection Forecasted Market Size by Country 8.2.1 Latin America Aprepitant Injection Sales in Volume by Country (2024-2029) 8.2.2 Latin America Aprepitant Injection Sales in Value by Country (2024-2029) 9 Middle East and Africa Aprepitant Injection by Country 9.1 Middle East and Africa Aprepitant Injection Historic Market Size by Country 9.1.1 Middle East and Africa Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Aprepitant Injection Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Aprepitant Injection Forecasted Market Size by Country 9.2.1 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Aprepitant Injection Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Heron Therapeutics, Inc. 10.1.1 Heron Therapeutics, Inc. Company Information 10.1.2 Heron Therapeutics, Inc. Introduction and Business Overview 10.1.3 Heron Therapeutics, Inc. Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Heron Therapeutics, Inc. Aprepitant Injection Products Offered 10.1.5 Heron Therapeutics, Inc. Recent Development 10.2 Qilu Pharmaceutical 10.2.1 Qilu Pharmaceutical Company Information 10.2.2 Qilu Pharmaceutical Introduction and Business Overview 10.2.3 Qilu Pharmaceutical Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Qilu Pharmaceutical Aprepitant Injection Products Offered 10.2.5 Qilu Pharmaceutical Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Aprepitant Injection Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Aprepitant Injection Industrial Chain Analysis 11.4 Aprepitant Injection Market Dynamics 11.4.1 Aprepitant Injection Industry Trends 11.4.2 Aprepitant Injection Market Drivers 11.4.3 Aprepitant Injection Market Challenges 11.4.4 Aprepitant Injection Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Aprepitant Injection Distributors 12.3 Aprepitant Injection Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
SummaryArepidan injection is a submicron emulsion prepared by wrapping Arepidan in soybean oil. Compared with oral preparation, it can significantly improve the bioavailability and drug compliance; At the same time, it can effectively reduce the incidence of anaphylaxis in the clinical use of similar injection preparations. It is a prescription drug for the treatment of nausea and vomiting caused by chemotherapy. It can be used alone or together with other drugs. Table of Contents1 Aprepitant Injection Market Overview1.1 Aprepitant Injection Product Overview 1.2 Aprepitant Injection Market Segment by Type 1.2.1 Injection 1.2.2 Injection Lotion 1.3 Global Aprepitant Injection Market Size by Type 1.3.1 Global Aprepitant Injection Market Size Overview by Type (2018-2029) 1.3.2 Global Aprepitant Injection Historic Market Size Review by Type (2018-2023) 1.3.3 Global Aprepitant Injection Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.2 Europe Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Aprepitant Injection Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Type (2018-2023) 2 Global Aprepitant Injection Market Competition by Company 2.1 Global Top Players by Aprepitant Injection Sales (2018-2023) 2.2 Global Top Players by Aprepitant Injection Revenue (2018-2023) 2.3 Global Top Players by Aprepitant Injection Price (2018-2023) 2.4 Global Top Manufacturers Aprepitant Injection Manufacturing Base Distribution, Sales Area, Product Type 2.5 Aprepitant Injection Market Competitive Situation and Trends 2.5.1 Aprepitant Injection Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Aprepitant Injection Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aprepitant Injection as of 2022) 2.7 Date of Key Manufacturers Enter into Aprepitant Injection Market 2.8 Key Manufacturers Aprepitant Injection Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Aprepitant Injection Status and Outlook by Region 3.1 Global Aprepitant Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Aprepitant Injection Historic Market Size by Region 3.2.1 Global Aprepitant Injection Sales in Volume by Region (2018-2023) 3.2.2 Global Aprepitant Injection Sales in Value by Region (2018-2023) 3.2.3 Global Aprepitant Injection Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Aprepitant Injection Forecasted Market Size by Region 3.3.1 Global Aprepitant Injection Sales in Volume by Region (2024-2029) 3.3.2 Global Aprepitant Injection Sales in Value by Region (2024-2029) 3.3.3 Global Aprepitant Injection Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Aprepitant Injection by Application 4.1 Aprepitant Injection Market Segment by Application 4.1.1 Cancer Treatment Center 4.1.2 Hospital 4.2 Global Aprepitant Injection Market Size by Application 4.2.1 Global Aprepitant Injection Market Size Overview by Application (2018-2029) 4.2.2 Global Aprepitant Injection Historic Market Size Review by Application (2018-2023) 4.2.3 Global Aprepitant Injection Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.2 Europe Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Aprepitant Injection Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Aprepitant Injection Sales Breakdown by Application (2018-2023) 5 North America Aprepitant Injection by Country 5.1 North America Aprepitant Injection Historic Market Size by Country 5.1.1 North America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Aprepitant Injection Sales in Volume by Country (2018-2023) 5.1.3 North America Aprepitant Injection Sales in Value by Country (2018-2023) 5.2 North America Aprepitant Injection Forecasted Market Size by Country 5.2.1 North America Aprepitant Injection Sales in Volume by Country (2024-2029) 5.2.2 North America Aprepitant Injection Sales in Value by Country (2024-2029) 6 Europe Aprepitant Injection by Country 6.1 Europe Aprepitant Injection Historic Market Size by Country 6.1.1 Europe Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Aprepitant Injection Sales in Volume by Country (2018-2023) 6.1.3 Europe Aprepitant Injection Sales in Value by Country (2018-2023) 6.2 Europe Aprepitant Injection Forecasted Market Size by Country 6.2.1 Europe Aprepitant Injection Sales in Volume by Country (2024-2029) 6.2.2 Europe Aprepitant Injection Sales in Value by Country (2024-2029) 7 Asia-Pacific Aprepitant Injection by Region 7.1 Asia-Pacific Aprepitant Injection Historic Market Size by Region 7.1.1 Asia-Pacific Aprepitant Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Aprepitant Injection Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Aprepitant Injection Forecasted Market Size by Region 7.2.1 Asia-Pacific Aprepitant Injection Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Aprepitant Injection Sales in Value by Region (2024-2029) 8 Latin America Aprepitant Injection by Country 8.1 Latin America Aprepitant Injection Historic Market Size by Country 8.1.1 Latin America Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Aprepitant Injection Sales in Volume by Country (2018-2023) 8.1.3 Latin America Aprepitant Injection Sales in Value by Country (2018-2023) 8.2 Latin America Aprepitant Injection Forecasted Market Size by Country 8.2.1 Latin America Aprepitant Injection Sales in Volume by Country (2024-2029) 8.2.2 Latin America Aprepitant Injection Sales in Value by Country (2024-2029) 9 Middle East and Africa Aprepitant Injection by Country 9.1 Middle East and Africa Aprepitant Injection Historic Market Size by Country 9.1.1 Middle East and Africa Aprepitant Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Aprepitant Injection Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Aprepitant Injection Forecasted Market Size by Country 9.2.1 Middle East and Africa Aprepitant Injection Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Aprepitant Injection Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Heron Therapeutics, Inc. 10.1.1 Heron Therapeutics, Inc. Company Information 10.1.2 Heron Therapeutics, Inc. Introduction and Business Overview 10.1.3 Heron Therapeutics, Inc. Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Heron Therapeutics, Inc. Aprepitant Injection Products Offered 10.1.5 Heron Therapeutics, Inc. Recent Development 10.2 Qilu Pharmaceutical 10.2.1 Qilu Pharmaceutical Company Information 10.2.2 Qilu Pharmaceutical Introduction and Business Overview 10.2.3 Qilu Pharmaceutical Aprepitant Injection Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Qilu Pharmaceutical Aprepitant Injection Products Offered 10.2.5 Qilu Pharmaceutical Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Aprepitant Injection Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Aprepitant Injection Industrial Chain Analysis 11.4 Aprepitant Injection Market Dynamics 11.4.1 Aprepitant Injection Industry Trends 11.4.2 Aprepitant Injection Market Drivers 11.4.3 Aprepitant Injection Market Challenges 11.4.4 Aprepitant Injection Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Aprepitant Injection Distributors 12.3 Aprepitant Injection Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポートQYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(injection)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |